News

Moderna Files FDA Application for the LP.8.1 Targeting COVID-19 Vaccine
CAMBRIDGE, MA / ACCESS Newswire / May 23, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that it has submitted an ...
FDA may limit future Covid-19 shots to older people and those at risk of serious infection
The US Food and Drug Administration is changing the way it approves Covid-19 vaccines for Americans, a move that may limit ...
Who can get updated COVID vaccines this fall? FDA will OK for high-risk groups, calls for new clinical trials
The Food and Drug Administration says it has decided to continue approving COVID-19 vaccine updates for seniors and others at ...
Healio4d
FDA will restrict future COVID-19 vaccines based on age, risk factors
FDA officials outlined new restrictions for COVID-19 vaccines that could limit their use in the United States.
What's the future of COVID-19 vaccines in Australia after US restricts access?
The US Food and Drug Administration is changing how it approves COVID-19 vaccines for Americans. What does that mean for ...
FDA Updates COVID-19 Vaccine Regulations—Here’s What to Know
The FDA has updated COVID-19 vaccine regulations. Only people aged 65 and up, along with certain groups, will be eligible to ...
STAT4d
FDA will limit Covid vaccines to people over 65 or at high risk of serious illness, leaders say
The FDA announced it will limit access to Covid-19 vaccines going forward to people 65 and older and others at high risk of ...
Health News Florida4d
A stricter FDA policy for COVID vaccines could limit future access
Federal officials unveiled a rigorous regulatory approach to future COVID vaccines that could make it harder for many people ...
Infectious Disease Advisor2d
FDA’s New COVID-19 Vaccine Approval Policy May Limit Future Access
The FDA is implementing stricter guidance for the approval of COVID-19 vaccines, according to a paper published in The New England Journal of Medicine.
STAT2d
The FDA is circumventing key roles and procedures for licensure and use of Covid vaccines
The FDA’s recent activities regarding Covid-19 vaccines stray far from the well-established standards of vaccine regulatory processes.